NCT00992329View on ClinicalTrials.gov

Impact of Formulation on Ciprofloxacin Oral Absorption

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy
Interventions
DRUG

ciprofloxacin

ciprofloxacin 200mg tablet (single dose)

Trial Locations (1)

21201

University of Maryland, Baltimore

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

University of Maryland, Baltimore

OTHER

NCT00992329 - Impact of Formulation on Ciprofloxacin Oral Absorption | Biotech Hunter | Biotech Hunter